ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Ironwood Pharmaceuticals 

301 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-621-7722 Fax: 617-494-0908


SEARCH JOBS

Ironwood Pharmaceuticals (NASDAQ: IRWD) is focused on creating medicines that make a difference for patients, building value to earn the continued support of our fellow shareholders, and empowering our team to passionately pursue excellence. We discovered, developed and are commercializing linaclotide, which is approved in the United States and a number of other countries. Our pipeline priorities include exploring further opportunities for linaclotide, as well as leveraging our therapeutic expertise in gastrointestinal disorders and our pharmacologic expertise in guanylate cyclases to address patient needs across the upper and lower gastrointestinal tract. Ironwood was founded in 1998 and is headquartered in Cambridge, Mass. Connect with us at www.ironwoodpharma.com or on Twitter at www.twitter.com/ironwoodpharma.


 Key Statistics


Email:
Ownership: Public

Web Site: Ironwood Pharmaceuticals
Employees:
Symbol: IRWD
 



Industry
Pharmaceutical






 Company News
Ironwood Pharmaceuticals (IRWD) Presents IW-9179 Phase 2a Data At American College of Gastroenterology 2014 Annual Scientific Meeting 10/20/2014 1:00:01 PM
Ironwood Pharmaceuticals (IRWD) Announces Initiation Of Phase 2 Trial Of Linaclotide In Adult Patients With Opioid-Induced Constipation 10/16/2014 8:20:41 AM
Ironwood Pharmaceuticals (IRWD) To Host Third Quarter 2014 Investor Update Call 10/15/2014 9:00:04 AM
Ironwood Pharmaceuticals (IRWD) And Actavis (ACT) To Present Linaclotide Data At The American College of Gastroenterology 2014 Annual Scientific Meeting 10/9/2014 10:48:04 AM
Ironwood Pharmaceuticals (IRWD) To Present At Morgan Stanley Global Healthcare Conference 9/4/2014 12:40:25 PM
Ironwood Pharmaceuticals (IRWD) Appoints Two New Senior Executives To Support Continued Growth As A Leader In Gastroenterology 9/3/2014 12:50:06 PM
Ironwood Pharmaceuticals (IRWD) Provides Second Quarter 2014 Investor Update 8/5/2014 9:44:01 AM
Ironwood Pharmaceuticals (IRWD) To Host Second Quarter 2014 Investor Update Call 7/8/2014 11:45:21 AM
Ironwood Pharmaceuticals (IRWD) To Present At Goldman, Sachs & Co. Global Healthcare Conference 6/5/2014 7:48:16 AM
Ironwood Pharmaceuticals (IRWD) Appoints Douglas Williams, Ph.D., To Board Of Directors 6/4/2014 7:08:42 AM
12345678910...